# EDGAR Filing Document

**Accession Number:** 0001611115
**File Stem:** 0001628280-26-027935
**Filing Date:** 2026-4
**Character Count:** 4567
**Document Hash:** e27d78dcad541b49125f83c4bd3a5a17
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-027935.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001628280-26-027935

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Omada Health, Inc.
- **CENTRAL INDEX KEY:** 0001611115
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 452355015
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42679
- **FILM NUMBER:** 26907941

**BUSINESS ADDRESS:**
- **STREET 1:** 611 GATEWAY BLVD.
- **STREET 2:** SUITE 120
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 888-987-8337

**MAIL ADDRESS:**
- **STREET 1:** 2202 S. COCKRELL HILL ROAD
- **STREET 2:** P.O BOX 210129
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75211

**UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION<br>WASHINGTON, D.C. 20549<br>___________________________________<br>SCHEDULE 14A<br>Proxy Statement Pursuant to Section 14(a) of<br>the Securities Exchange Act of 1934 (Amendment No.)** 

Filed by the Registrant ☒<br>Filed by a party other than the Registrant ☐

<br>Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

**Omada Health, Inc.**

**(Name of Registrant as Specified In Its Charter)**

**<br>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)**

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

------

![](omadahealth-asmnotice001.jpg)

Your Vote Counts! OMADA HEALTH, INC. 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO, CALIFORNIA 94080 OMADA HEALTH, INC. 2026 Annual Meeting of Stockholders Vote by June 15, 2026 11:59 PM ET You invested in OMADA HEALTH, INC. and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held online at www.virtualshareholdermeeting.com/OMDA2026 on June 16, 2026 at 9:00 AM PT. Vote Virtually at the Meeting\* June 16, 2026 9:00 AM PT Virtually at: www.virtualshareholdermeeting.com/OMDA2026 \*Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V95949-P48508 Get informed before you vote View the Notice, Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 2, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

------

![](omadahealth-asmnotice002.jpg)

THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. We encourage you to access and review all of the important information contained in the proxy materials before voting. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click "Delivery Settings". Voting Items Board Recommends V95950-P48508 1. The election of two Class I directors to hold office until the 2029 Annual Meeting of Stockholders and until each such director's respective successor is elected and qualified. For Nominees: 01) Sean Duffy 02) Trevor Fetter 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

------